Completed OBSERVATIONAL NCT02156882

Establishment of a Clinical Trial Unit in Mavalane, Maputo, in Mozambique (MaTuTU)

Maputo Tuberculosis Trial Unit- Project (MaTuTU- Project)

Sponsor: Michael Hoelscher

Updated 10 times since 2017 Last updated: Mar 6, 2018 Started: Jun 30, 2014 Primary completion: May 31, 2016 Completion: Sep 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02156882, this observational or N/A phase trial focuses on Tuberculosis and remains completed. Sponsored by Michael Hoelscher, it has been updated 10 times since 2014, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed
Nov 2020 — Jan 2021 [monthly]

Completed

▶ Show 5 earlier versions

Jun 2018 — Nov 2020 [monthly]

Completed
May 2018 — Jun 2018 [monthly]

Completed
Apr 2018 — May 2018 [monthly]

Completed

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Completed NA
Jan 2017 — Aug 2017 [monthly]

Completed NA

First recorded

Jun 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Michael Hoelscher

Data source: Ludwig-Maximilians - University of Munich

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Maputo, Mozambique